ProShare Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Buy |
|
|||||
|
2025
Q1 | $2.04M | Buy |
|
|||||
|
2024
Q4 | $2.92M | Sell |
|
|||||
|
2024
Q3 | $28.7M | Buy |
|
|||||
|
2024
Q2 | $47.7M | Sell |
|
|||||
|
2024
Q1 | $47.4M | Buy |
|
|||||
|
2023
Q4 | $36.5M | Sell |
|
|||||
|
2023
Q3 | $44.3M | Buy |
|
|||||
|
2023
Q2 | $45.5M | Sell |
|
|||||
|
2023
Q1 | $62M | Buy |
|
|||||
|
2022
Q4 | $65.8M | Sell |
|
|||||
|
2022
Q3 | $49.5M | Sell |
|
|||||
|
2022
Q2 | $71.6M | Sell |
|
|||||
|
2022
Q1 | $131M | Sell |
|
|||||
|
2021
Q4 | $201M | Buy |
|
|||||
|
2021
Q3 | $210M | Buy |
|
|||||
|
2021
Q2 | $107M | Sell |
|
|||||
|
2021
Q1 | $61M | Buy |
|
|||||
|
2020
Q4 | $41.3M | Buy |
|
|||||
|
2020
Q3 | $24.4M | Buy |
|
|||||
|
2020
Q2 | $4.29M | Buy |
|
|||||
|
2020
Q1 | $1.49M | Sell |
|
|||||
|
2019
Q4 | $1.51M | Buy |
|